| Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study (NCT05169151) | M.D. Anderson Cancer Center | 2022-02-17 |
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors (NCT07259304) | University of Southern California | 2021-11-24 |
| Cerebrospinal Fluid Biomarkers for Brain Tumors (NCT04692324) | Mayo Clinic | 2021-01-14 |
| An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors (NCT04539574) | M.D. Anderson Cancer Center | 2020-09-04 |
| Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology (NCT04988009) | M.D. Anderson Cancer Center | 2020-08-20 |
| Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia (NCT03834961) | Children's Oncology Group | 2019-10-25 |
| Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System (NCT03270059) | OHSU Knight Cancer Institute | 2017-10-06 |
| Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery (NCT03071913) | Mayo Clinic | 2017-09-20 |
| Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (NCT03012620) | UNICANCER | 2017-07-05 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Project: Every Child for Younger Patients With Cancer (NCT02402244) | Children's Oncology Group | 2015-11-03 |
| High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors (NCT01941758) | Wake Forest University Health Sciences | 2013-11-01 |
| Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors (NCT01538095) | National Cancer Institute (NCI) | 2012-02-01 |
| Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors (NCT01474174) | Wake Forest University Health Sciences | 2011-09-01 |
| Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors (NCT01217437) | National Cancer Institute (NCI) | 2010-11-22 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas (NCT00100802) | Children's Oncology Group | 2005-03-21 |